| Balance Sheets | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 144,962 | 140,670 | 177,549 | 187,540 |
| Short-term available-for-sale investments | - | 0 | 0 | - |
| Accounts receivable, less allowances of 4,375 and 4,215, respectively | 183,897 | 237,140 | 217,940 | 223,688 |
| Inventories | 203,188 | 191,083 | 188,373 | 185,041 |
| Current assets held-for-sale | - | 4,700 | 1,047 | 9,459 |
| Other current assets | 77,460 | 53,647 | 49,731 | 42,839 |
| Total current assets | 609,507 | 627,240 | 634,640 | 648,567 |
| Property and equipment, net | 240,334 | 251,977 | 249,753 | 253,939 |
| Right-of-use assets | 70,725 | 83,744 | 85,383 | 89,221 |
| Goodwill | 978,912 | 968,612 | 964,607 | 982,585 |
| Intangible assets, net | 350,107 | 443,699 | 461,051 | 486,004 |
| Other assets | 276,563 | 268,987 | 274,990 | 275,701 |
| Total assets | 2,526,148 | 2,644,259 | 2,670,424 | 2,736,017 |
| Trade accounts payable | 30,157 | 31,644 | 33,120 | 31,559 |
| Salaries, wages and related accruals | 43,599 | 61,896 | 53,594 | 41,977 |
| Accrued expenses | 19,179 | 23,905 | 27,543 | 21,088 |
| Contract liabilities | 30,445 | 32,269 | 27,715 | 26,614 |
| Income taxes payable | 2,848 | 3,628 | 3,141 | 3,136 |
| Operating lease liabilities - current | 13,771 | 14,049 | 13,511 | 13,485 |
| Other current liabilities | 4,546 | 1,813 | 2,632 | 4,269 |
| Total current liabilities | 144,545 | 169,204 | 161,256 | 142,128 |
| Deferred income taxes | 11,273 | 31,924 | 37,723 | 50,017 |
| Long-term debt obligations | 300,000 | 330,000 | 300,000 | 300,000 |
| Operating lease liabilities | 80,702 | 79,450 | 81,616 | 85,433 |
| Other long-term liabilities | 23,814 | 15,656 | 11,337 | 19,789 |
| Undesignated capital stock, no par authorized 5,000,000 shares none issued or outstanding | 0 | 0 | 0 | 0 |
| Common stock, par value .01 per share authorized 400,000,000 issued and outstanding 155,749,477 and 154,972,196 respectively | 1,557 | 1,568 | 1,579 | 1,589 |
| Additional paid-in capital | 946,118 | 902,124 | 875,864 | 855,973 |
| Retained earnings | 1,082,534 | 1,196,385 | 1,286,699 | 1,341,175 |
| Accumulated other comprehensive loss | -64,395 | -82,052 | -85,650 | -60,087 |
| Total bio-techne's shareholders' equity | - | 2,018,025 | 2,078,492 | 2,138,650 |
| Total shareholders' equity | 1,965,814 | - | - | - |
| Total liabilities and shareholders' equity | 2,526,148 | 2,644,259 | 2,670,424 | 2,736,017 |
BIO-TECHNE Corp (TECH)
BIO-TECHNE Corp (TECH)